<DOC>
	<DOCNO>NCT03010280</DOCNO>
	<brief_summary>A prospective randomize clinical trial patient undergo Roux - en-Y gastric bypass perform . Patients randomly assign 2 group : patient receive preoperative balance energy high-protein formula ( group 1 ) receive preoperative Immunonutrition ( group 2 ) . Preoperative weight loss , postoperative septic complication analytical acute phase reactant investigate .</brief_summary>
	<brief_title>Effect Immunonutrition Septic Complications After Roux-en-Y Gastric Bypass</brief_title>
	<detailed_description>A prospective randomize clinical trial patient undergo Roux - en-Y gastric bypass perform . Patients randomly assign 2 group : patient receive preoperative balance energy high-protein formula ( group 1 ) receive preoperative Immunonutrition ( group 2 ) . Postoperative septic complication ( anastomotic leak organ/space SSI ) analytical acute phase reactant ( white blood cell count C reactive protein ) investigate .</detailed_description>
	<mesh_term>Postoperative Complications</mesh_term>
	<criteria>body mass index ( BMI ) &gt; 40 kg/m2 BMI &gt; 35 kg/m2 presence comorbidities associate obesity Patients undergoing RouxenY gastric bypass bariatric procedure Patients undergo bariatric technique different RouxenY gastric bypass gastroesophageal reflux patient uncontrolled psychiatric disorder active infection malignancy concomitant pathology consider contraindication bariatric surgery .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>